pinocembrin has been researched along with Cardiac Failure in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Fo, Y; Guo, Y; Qu, C; Sun, Y; Wan, W; Yang, B; Ye, T; Zhang, C | 1 |
| Chen, X; Guo, Y; Liang, J; Liu, X; Qu, C; Shi, S; Sun, Y; Yang, B; Ye, T; Zhang, C | 1 |
2 other study(ies) available for pinocembrin and Cardiac Failure
| Article | Year |
|---|---|
Pinocembrin ameliorates post-infarct heart failure through activation of Nrf2/HO-1 signaling pathway.
Topics: Animals; Antioxidants; Biomarkers; Disease Management; Disease Models, Animal; Disease Susceptibility; Echocardiography; Flavanones; Heart Failure; Heme Oxygenase-1; Immunohistochemistry; Male; Myocardial Infarction; Myocytes, Cardiac; Myofibroblasts; NF-E2-Related Factor 2; Oxidative Stress; Rats; Reactive Oxygen Species; Signal Transduction | 2021 |
Pinocembrin ameliorates arrhythmias in rats with chronic ischaemic heart failure.
Topics: Animals; Arrhythmias, Cardiac; Disease Models, Animal; Flavanones; Heart Failure; Humans; Myocardial Infarction; Nerve Growth Factor; Rats | 2021 |